Trial Site Detail

 

Drug:
XL765
Trial:
Study of the Safety and Pharmacokinetics of XL765 in Adults With Solid Tumors
Conditions: Solid Tumors
Trial Status:
Ongoing, but not recruiting

 

South Texas Accelerated Research Therapeutics (START)

4319 Medical Dr.     
San Antonio , TX 78229
USA

 

Principal Investigator:
Kyriakos Papadopoulos, MD
Contact:
Gina Mangold, MBA 210-593-5250 gmangold@start.stoh.com
Activation Status of this Site:
Closed
Notes about this Site:
South Texas Accelerated Research Therapeutics (START) Website:
http://www.startthecure.com/clinical-trials.html

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.